Skip to main content
Jared Baeten, MD, Infectious Disease, Seattle, WA

JaredMurrayBaetenMD

Infectious Disease Seattle, WA

Associate Professor, Global Health and Community Medicine, University of Washington School of Medicine

Dr. Baeten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Baeten's full profile

Already have an account?

  • Office

    325 9th Ave
    Campus Box 359927
    Seattle, WA 98104
    Phone+1 206-520-3808
    Fax+1 206-520-3801

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 2006 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2003

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2006 - 2025
  • MA State Medical License
    MA State Medical License 2005 - 2008
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Short Message Service (SMS) Surveys Assessing Pre-Exposure Prophylaxis (PrEP) Adherence and Sexual Behavior Are Highly Acceptable Among HIV-Uninfected Members of Serod...  
    Jared M Baeten, Jessica E Haberer, AIDS and Behavior
  • Quadrivalent HPV Vaccine in HIV-1-Infected Early Adolescent Girls and Boys in Kenya: Month 7 and 12 Post Vaccine Immunogenicity and Correlation with Immune Status  
    Linda Eckert, Connie Celum, Jared M Baeten, ScienceDirect
  • Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis  
    Jared Baeten, MD, Open Forum Infectious Diseases
  • Join now to see all

Press Mentions

  • Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
    Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV GlasgowNovember 13th, 2024
  • Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
    Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and PipelineNovember 12th, 2024
  • Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
    Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the EpidemicNovember 7th, 2024
  • Join now to see all

Grant Support

  • PREP And Protective Immune Responses Against HIV-1National Institute Of Allergy And Infectious Diseases2012
  • Evaluation Of Antiretroviral HIV Prevention In African HIV Discordant CouplesNational Institute Of Nursing Research2011–2012
  • Optimizing Antiretroviral-Based HIV Prevention For HIV Serodiscordant CouplesNational Institute Of Mental Health2011
  • Contraception, PREGNANCY, And HIV-1 Risk In African HIV-1 Serodiscordant CouplesEunice Kennedy Shriver National Institute Of Child Health &Human Development2011

Professional Memberships